RETRACTED: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer.
作者信息
Sun Cheng-Cao, Li Shu-Jun, Hu Wei, Zhang Jian, Zhou Qun, Liu Cong, Li Lin-Lin, Songyang Yi-Yan, Zhang Feng, Chen Zhen-Long, Li Guang, Bi Zhuo-Yue, Bi Yong-Yi, Gong Feng-Yun, Bo Tao, Yuan Zhan-Peng, Hu Wei-Dong, Zhan Bo-Tao, Zhang Qian, He Qi-Qiang, Li De-Jia
机构信息
Department of Occupational and Environmental Health, School of Health Sciences, Wuhan University, Wuhan 430071, Hubei, China; Department of Molecular and Cellular Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Wuhan Hospital for the Prevention and Treatment of Occupational Diseases, Wuhan 430022, Hubei, China.
出版信息
Mol Ther. 2019 Jun 5;27(6):1153-1165. doi: 10.1016/j.ymthe.2019.03.019. Epub 2019 Apr 6.
Abstract
摘要
相似文献
1
RETRACTED: Comprehensive Analysis of the Expression and Prognosis for E2Fs in Human Breast Cancer.撤回：人类乳腺癌中E2F表达与预后的综合分析
Mol Ther. 2019 Jun 5;27(6):1153-1165. doi: 10.1016/j.ymthe.2019.03.019. Epub 2019 Apr 6.
2
Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.雌激素受体 1 和孕激素受体是雌激素受体阳性乳腺癌的独特生物标志物和预后因素：来自生物信息学分析的证据。
Biomed Pharmacother. 2020 Jan;121:109647. doi: 10.1016/j.biopha.2019.109647. Epub 2019 Nov 13.
3
Expression Profile and Prognostic Values of Mini-Chromosome Maintenance Families (MCMs) in Breast Cancer.微小染色体维持蛋白家族（MCMs）在乳腺癌中的表达谱及预后价值
Med Sci Monit. 2020 Aug 24;26:e923673. doi: 10.12659/MSM.923673.
4
Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.临床乳腺癌患者中 Tob/BTG 垂体肿瘤转化基因（PTTG）家族的基因特征和预后分析。
Int J Med Sci. 2020 Oct 22;17(18):3112-3124. doi: 10.7150/ijms.49652. eCollection 2020.
5
A favorable role of prolactin in human breast cancer reveals novel pathway-based gene signatures indicative of tumor differentiation and favorable patient outcome.催乳素在人类乳腺癌中的有利作用揭示了基于新途径的基因特征，这些特征表明肿瘤分化良好且患者预后良好。
Hum Pathol. 2016 Jul;53:142-52. doi: 10.1016/j.humpath.2016.02.010. Epub 2016 Mar 14.
6
The transcriptional STAT3 is a potential target, whereas transcriptional STAT5A/5B/6 are new biomarkers for prognosis in human breast carcinoma.转录因子STAT3是一个潜在靶点，而转录因子STAT5A/5B/6是人类乳腺癌预后的新生物标志物。
Oncotarget. 2017 May 30;8(22):36279-36288. doi: 10.18632/oncotarget.16748.
7
Clinical Significance of and in Human Breast Cancer.[文中未明确的两个因素]在人类乳腺癌中的临床意义。
Anticancer Res. 2017 Aug;37(8):4249-4254. doi: 10.21873/anticanres.11817.
8
MiR-17-5p may serve as a novel predictor for breast cancer recurrence.miR-17-5p 可能成为乳腺癌复发的一个新预测因子。
Cancer Biomark. 2018;22(4):721-726. doi: 10.3233/CBM-181228.
9
High FAS expression correlates with a better prognosis and efficacy of taxanes and target regents in breast cancer.高 FAS 表达与乳腺癌中紫杉烷和靶向药物的更好预后和疗效相关。
Cancer Biomark. 2021;32(2):207-219. doi: 10.3233/CBM-203125.
10
The Expression Level of () mRNA in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.（）mRNA 在外周血中的表达水平可能是预测乳腺癌复发的生物标志物。
Anticancer Res. 2020 Jul;40(7):3733-3742. doi: 10.21873/anticanres.14362.
引用本文的文献
1
Insights into the E2F target genes in breast cancer: associations of pathway genes with prognosis and immune cell filtration based on in silico and ex vivo analyses.乳腺癌中E2F靶基因的见解：基于计算机模拟和体外分析的通路基因与预后及免疫细胞浸润的关联
Cancer Cell Int. 2025 Jun 6;25(1):203. doi: 10.1186/s12935-025-03839-2.
2
Liposomal Nano-Based Drug Delivery Systems for Breast Cancer Therapy: Recent Advances and Progresses.基于脂质体的纳米药物递送系统用于乳腺癌治疗：最新进展。
Anticancer Agents Med Chem. 2024;24(12):896-915. doi: 10.2174/0118715206293653240322041047.
3
Expression patterns of E2Fs identify tumor microenvironment features in human gastric cancer.E2Fs 的表达模式可识别人类胃癌中的肿瘤微环境特征。
PeerJ. 2024 Feb 13;12:e16911. doi: 10.7717/peerj.16911. eCollection 2024.
4
CX3CR1 is a potential biomarker of immune microenvironment and prognosis in epithelial ovarian cancer.CX3CR1 是上皮性卵巢癌免疫微环境和预后的潜在生物标志物。
Medicine (Baltimore). 2024 Jan 19;103(3):e36891. doi: 10.1097/MD.0000000000036891.
5
E2F7 serves as a potential prognostic biomarker for lung adenocarcinoma.E2F7 可作为肺腺癌的潜在预后生物标志物。
Medicine (Baltimore). 2024 Jan 19;103(3):e34342. doi: 10.1097/MD.0000000000034342.
6
Biomarker potential of the LEF1/TCF family members in breast cancer: Bioinformatic investigation on expression and clinical significance.LEF1/TCF家族成员在乳腺癌中的生物标志物潜力：关于表达及临床意义的生物信息学研究
Genet Mol Biol. 2023 Dec 15;46(4):e20220346. doi: 10.1590/1678-4685-GMB-2022-0346. eCollection 2023.
7
Single-cell Analysis Reveals Inter- and Intratumour Heterogeneity in Metastatic Breast Cancer.单细胞分析揭示转移性乳腺癌的肿瘤内和肿瘤间异质性。
J Mammary Gland Biol Neoplasia. 2023 Dec 8;28(1):26. doi: 10.1007/s10911-023-09551-z.
8
Aquaporin 1 overexpression may enhance glioma tumorigenesis by interacting with the transcriptional regulation networks of Foxo4, Maz, and E2F families.水通道蛋白1的过表达可能通过与Foxo4、Maz和E2F家族的转录调控网络相互作用来增强胶质瘤的肿瘤发生。
Chin Neurosurg J. 2023 Dec 6;9(1):34. doi: 10.1186/s41016-023-00342-3.
9
Characteristics of mA-related LncRNAs in breast cancer as prognostic biomarkers and immunotherapy.乳腺癌中与毫安相关的长链非编码RNA作为预后生物标志物和免疫治疗的特征
J Cancer. 2023 Sep 11;14(15):2919-2930. doi: 10.7150/jca.87079. eCollection 2023.
10
Development of a novel immune infiltration-related diagnostic model for Alzheimer's disease using bioinformatic strategies.利用生物信息学策略开发一种新型的阿尔茨海默病免疫浸润相关诊断模型。
Front Immunol. 2023 Jul 20;14:1147501. doi: 10.3389/fimmu.2023.1147501. eCollection 2023.
本文引用的文献
1
Long noncoding RNA LINC00511 contributes to breast cancer tumourigenesis and stemness by inducing the miR-185-3p/E2F1/Nanog axis.长链非编码 RNA LINC00511 通过诱导 miR-185-3p/E2F1/Nanog 轴促进乳腺癌肿瘤发生和干性。
J Exp Clin Cancer Res. 2018 Nov 27;37(1):289. doi: 10.1186/s13046-018-0945-6.
2
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018：GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
3
A miR-26a/E2F7 feedback loop contributes to tamoxifen resistance in ER-positive breast cancer.miR-26a/E2F7 反馈环路促进 ER 阳性乳腺癌对他莫昔芬耐药。
Int J Oncol. 2018 Oct;53(4):1601-1612. doi: 10.3892/ijo.2018.4492. Epub 2018 Jul 19.
4
Oncoprotein HBXIP induces PKM2 via transcription factor E2F1 to promote cell proliferation in ER-positive breast cancer.癌蛋白 HBXIP 通过转录因子 E2F1 诱导 PKM2 的表达，从而促进 ER 阳性乳腺癌细胞的增殖。
Acta Pharmacol Sin. 2019 Apr;40(4):530-538. doi: 10.1038/s41401-018-0015-9. Epub 2018 Jun 20.
5
Circular RNA hsa_circ_0008039 promotes breast cancer cell proliferation and migration by regulating miR-432-5p/E2F3 axis.环状 RNA hsa_circ_0008039 通过调控 miR-432-5p/E2F3 轴促进乳腺癌细胞的增殖和迁移。
Biochem Biophys Res Commun. 2018 Jul 20;502(3):358-363. doi: 10.1016/j.bbrc.2018.05.166. Epub 2018 May 31.
6
MicroRNA-129-3p suppresses tumor growth by targeting E2F5 in glioblastoma.微小 RNA-129-3p 通过靶向神经胶质瘤中的 E2F5 抑制肿瘤生长。
Eur Rev Med Pharmacol Sci. 2018 Feb;22(4):1044-1050. doi: 10.26355/eurrev_201802_14387.
7
Identification of tumor suppressive role of microRNA-132 and its target gene in tumorigenesis of prostate cancer.鉴定 microRNA-132 及其靶基因在前列腺癌肿瘤发生中的肿瘤抑制作用。
Int J Mol Med. 2018 Apr;41(4):2429-2433. doi: 10.3892/ijmm.2018.3421. Epub 2018 Jan 23.
8
Shrimp miR-34 from Shrimp Stress Response to Virus Infection Suppresses Tumorigenesis of Breast Cancer.来自虾应激反应以应对病毒感染的虾miR-34抑制乳腺癌的肿瘤发生。
Mol Ther Nucleic Acids. 2017 Dec 15;9:387-398. doi: 10.1016/j.omtn.2017.10.016. Epub 2017 Oct 26.
9
Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancer.长链非编码 RNA TUG1 的下调与乳腺癌细胞的增殖、迁移和侵袭有关。
Biomed Pharmacother. 2017 Nov;95:1636-1643. doi: 10.1016/j.biopha.2017.09.076. Epub 2017 Oct 6.
10
microRNA‑372 inhibits proliferation and induces apoptosis in human breast cancer cells by directly targeting E2F1.microRNA-372 通过直接靶向 E2F1 抑制人乳腺癌细胞的增殖并诱导细胞凋亡。
Mol Med Rep. 2017 Dec;16(6):8069-8075. doi: 10.3892/mmr.2017.7591. Epub 2017 Sep 22.
Zotero 插件